---
category: drugs
aliases:
---

# semaglutide


Drug-Category :

GLP-1 receptor agonsit
GLUCAGON LIKE PEPTIDE -1 RECEPTOR AGONIST
increases insulin secretion and inhibits glucagon release

Brand Names :
OZEMPIC

Doses:
injectable(once a week) and oral (once a day )

Indications:
chronic weight management 
type 2 diabetes

Side Effects :

nausea vomitting diarrhoea abdominal pain pancratitis allergy
DON'T use in :



## References

### Related

[[Semaglutide and thyroid cancer risk]]


2024-08-07 : 14:45 

